Celgene and Evotec both invested in Exscientia, as the automated drug discovery services provider added Roche to its roster of development partners.

Celgene and Evotec have put capital into Exscientia as the Dundee-founded automated drug discovery services provider added Roche to its roster of development partners.

Unilever was among the existing investors that supplied $22.9m for meal kit provider Gousto, increasing its funding to about $100m to date.

Lidar technology developer Baraja has lured the support of Csiro's Innovation Fund as it pursues additional business for its autonomous vehicle perception system in the US and Asia.

Investors including Nan Fung and Tekla Capital have increased the ophthalmic treatment developer's series B round to $35.9m, following a Novartis-led tranche a year ago.

Xiamen C&D has taken part in a $29.1m round for Jinda Nano Tech that will fuel the antibacterial product maker's research into nanotechnology.

Lundbeckfonden Ventures and Alexandria Venture Investments both backed a series A round for tumour and endocrine disease drug developer Tiburio.

Alexandria Venture Investments has taken part in the final close of the series B round, which will fund development of the company's cell therapy platform.

NetEase has invested $30m in the game studio that will be used to hire staff and develop a debut game that will be released in partnership with Marvel.

A subsidiary of Suning has backed the community e-commerce platform's series A round, with the proceeds to fund geographic expansion and enhancement of its supply chain.